Sameer Avasarala, MD
-
Primary Location: 1000 Auburn Dr (5 mi.)
Other Locations - Languages Spoken: English, Telugu
Office Locations
UH Ahuja Risman Pavilion (5 mi.)
1000 Auburn Dr
Ste 200
Beachwood, OH 44122
216-593-5864
UH Cleveland Medical Center Bolwell (0 mi.)
11100 Euclid Ave
Bolwell 6th Floor
Cleveland, OH 44106
216-844-8500
UH Ahuja Risman Pavilion (5 mi.)
1000 Auburn Dr
Ste 130
Beachwood, OH 44122
216-844-8500
UH Ahuja Risman Pavilion (5 mi.)
1000 Auburn Dr
Ste 140
Beachwood, OH 44122
216-285-4033
Biography: Sameer Avasarala, MD
Expertise
Titles
- Clinical Instructor, CWRU School of Medicine
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Critical Care Medicine - American Board of Internal Medicine
- Pulmonary Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Education
Fellowship | Interventional Pulmonary Medicine
Interventional Pulmonary Medicine - Vanderbilt University Medical Center (2020 - 2021)
Fellowship | Pulmonary/Critical Care
Pulmonary/Critical Care - Cleveland Clinic (2017 - 2020)
Residency | Internal Medicine/Chief Resident
Internal Medicine/Chief Resident - Henry Ford Hospital (2016 - 2017)
Residency | Internal Medicine
Internal Medicine - Henry Ford Hospital (2013 - 2016)
Medical Education
Kamineni Institute Of Medical Sciences (2011)
About
Sameer Avasarala, MD, is an attending physician at University Hospitals and an Assistant Professor of Medicine at Case Western Reserve University School of Medicine. He specializes in minimally invasive diagnostic and therapeutic procedures of the lungs, airways, and the pleural space. He is board certified in internal medicine, pulmonary disease, critical care medicine, and interventional pulmonology.
Dr. Avasarala earned his medical degree from Kamineni Institute of Medical Sciences in Telangana, India. He completed his residency in Internal Medicine at Henry Ford Hospital in Detroit, Michigan, where he also served as a Chief Resident. He moved to Cleveland, Ohio, in 2017 and completed a Pulmonary and Critical Care Medicine fellowship at the Cleveland Clinic, where he served as an Instructor in Medicine at the Cleveland Clinic Lerner College of Medicine. Before joining University Hospitals in 2021, he completed an interventional pulmonology fellowship at Vanderbilt University in Nashville, Tennessee.
Dr. Avasarala has a specific research interest in interventional pulmonology. As of 2022, he has published over 20 peer-reviewed journal articles. He has been elected to the steering committee of the Interventional Procedures Section of the American College of Chest Physicians (CHEST). Additionally, he is an Associate Editor for the American Association for Bronchology and Interventional Pulmonology Podcasts. He also serves as a reviewer for the Journal of Bronchology and Interventional Pulmonology.
Dr. Avasarala has been awarded the 2022 CHEST Young Investigator Grant to research the application of dual-energy computed tomography in patients undergoing bronchoscopic lung volume reduction and the is the site principal investigator for a multicenter trial assessing pleural effusion management.
As a University Hospital interventional pulmonologist, he collaborates closely with the experts in thoracic oncology, otorhinolaryngology, and thoracic surgery at University Hospitals to manage a variety of disease conditions using the latest technological advances in bronchoscopy, including robotic bronchoscopy and bronchoscopic lung volume reduction.
Featured Videos
Watch to find out more about this University Hospitals provider.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sameer Avasarala did not disclose any Outside Relationships with Industry.